Retatrutide Swiss Elite Laboratories 60 mg represents an innovative peptide compound being investigated for its activity across GLP-1, GIP, and glucagon receptor pathways. Its unique triple-agonist mechanism makes it an interesting subject within contemporary metabolic research. Scientific investigations may explore its relationship with appetite signaling, energy expenditure, metabolic processes, and body composition. Swiss Elite Laboratories presents this 60 mg research compound for laboratory and analytical applications, offering researchers an opportunity to study one of the most closely investigated emerging peptides in metabolic science.